Skip to main content

Table 1 Ten lncRNAs and eight mRNAs selected as prognostic RNAs

From: An eight-mRNA signature outperforms the lncRNA-based signature in predicting prognosis of patients with glioblastoma

TypeIDcoefficientP-valueHR95%CIX-tile cutoff
lncRNAHOXB-AS30.0740.0071.3501.086–1.6760.87
LGALS8-AS10.1220.0141.2921.053–1.5840.20
LINC00032−0.0030.0200.7950.656–0.9630.20
LINC003110.0600.0011.4811.173–1.868−2.01
LINC00494−0.0040.0130.8420.672–0.952−0.14
LINC005440.0210.0211.2651.035–1.5430.02
LINC005890.0670.0191.1470.934–1.4070.00
LINC00626−0.0050.0180.7700.619–0.9560.00
MEIS1-AS3−0.0530.0400.8030.650–0.9890.15
VAV3-AS10.1040.0421.2250.998–1.502−0.09
mRNAASIC50.0650.0351.2461.016–1.528−1.67
CGB70.0720.0031.4051.124–1.756−0.47
CLDN160.1230.0061.3721.096–1.717−2.39
HAPLN40.1430.0001.5181.228–1.877−2.03
KRT130.0840.0021.3621.123–1.652−0.01
LCN90.0590.0121.3001.060–1.595−0.22
SOST0.0330.0181.1481.038–1.4040.60
TNS40.0280.0411.2311.009–1.503−0.14
  1. HR Hazard ratio, CI Confidential interval